NEAT and Daily Steps on a GLP-1 Microdose: The Energy You Stop Burning Without Noticing

A GLP-1 lowers how much you eat. It says nothing about how much you move, and that second number tends to drift down on its own once the first one falls.

The drift happens in the least visible part of the energy budget. Scientists call it NEAT, short for non exercise activity thermogenesis: the walking to the car, the standing while the kettle boils, the pacing on phone calls. James Levine at the Mayo Clinic spent two decades measuring it and found that NEAT varies between people by up to 2,000 kcal a day. Gym sessions rarely come close to that.

This article covers what NEAT is, why eating less tends to reduce it, how many calories daily steps actually burn, what the S-LiTE trial showed when exercise was added to a GLP-1, how many steps the mortality data supports, and why a short walk after meals is worth building into a microdose protocol.

What is NEAT, and how much of your daily burn does it account for?

The biggest lever most people ignore

NEAT is the energy spent on all movement that is not sleeping, eating, or deliberate exercise, and in most adults it accounts for 15 to 30 percent of total daily energy expenditure. Resting metabolism takes the largest share, around 60 percent. Digesting food takes about 10 percent. Planned exercise, for the average person, contributes less than people expect, often 5 to 10 percent across a full week.

NEAT is also the component with the widest range. Levine's review in Best Practice and Research Clinical Endocrinology and Metabolism (2002) put it at around 6 to 10 percent of daily energy use in very sedentary people and 50 percent or more in people with physically active jobs. Two people with the same weight and the same resting metabolism can differ by several hundred calories a day on NEAT alone.

Levine's 2005 study in Science fitted 20 volunteers with posture sensors for 10 days. The participants with obesity sat for about 164 minutes a day longer than the lean participants. Levine estimated that matching the lean group's upright time would burn roughly 350 extra kcal a day, without a single gym session.

Why does daily movement drop when you eat less on a GLP-1?

The body defends its energy budget

Daily movement usually drops during a calorie deficit because the body treats lower intake as a signal to conserve energy, and NEAT is the easiest place to cut. The effect is not unique to GLP-1 medicines. It shows up in dieting studies, in overfeeding studies run in reverse, and in the long term follow up of people who have lost weight.

Levine's 1999 overfeeding study in Science showed the mechanism from the other side. Sixteen volunteers ate an extra 1,000 kcal a day for eight weeks. Changes in NEAT ranged from a fall of 98 kcal to a rise of 692 kcal a day, and that variation predicted who resisted fat gain. The body turns NEAT up when energy is plentiful and down when it is scarce.

Rosenbaum and Leibel at Columbia measured the downward side. People who had lost 10 percent of body weight burned roughly 300 to 400 kcal a day less than their new size predicted, and most of the gap came from non resting energy expenditure. Their 2005 study in the Journal of Clinical Investigation found skeletal muscle became about 20 percent more efficient at low intensity work after weight loss, so the same everyday movements cost less energy.

GLP-1 medicines add a few practical reasons on top. Nausea in the first weeks makes the sofa more appealing. Lower food intake can leave people feeling flat in the afternoon, which the fatigue article on this site covers. None of the large semaglutide or tirzepatide trials tracked daily steps with accelerometers, so the size of the drop on these drugs specifically has not been measured.

How many calories do daily steps actually burn?

Small per step, large per month

An 80 kg adult walking at an easy pace burns roughly 30 to 40 kcal above resting for every 1,000 steps. That puts 10,000 steps at around 350 kcal. A 60 kg person burns closer to 25 to 30 kcal per 1,000 steps, and a 110 kg person closer to 45 to 50, because the cost of walking scales with body weight.

Per step, the numbers look trivial. Over a month they are not. A drop from 8,000 to 5,000 steps a day costs about 105 kcal a day for an 80 kg adult, or roughly 3,150 kcal a month. For someone on a low dose GLP-1 whose intake has fallen by 300 to 400 kcal a day, a slide in steps of that size can quietly remove a quarter to a third of the deficit.

The effect is larger on a microdose protocol than on a full dose. A full dose suppresses appetite hard enough that a 100 kcal change in movement barely registers. A microdose creates a gentler deficit, so movement makes up a bigger share of the total. The plateau article on this site covers the other reasons weight loss slows.

Does adding exercise to a GLP-1 improve results?

The S-LiTE trial answered it directly

Adding exercise to a GLP-1 improved weight maintenance in the one large randomized trial designed to test it. The S-LiTE trial, published by Lundgren and colleagues in the New England Journal of Medicine in 2021, enrolled 195 adults with obesity in Copenhagen. Participants first lost an average of about 13 kg on an eight week low calorie diet. They were then randomized to placebo, an exercise program, liraglutide 3.0 mg daily, or exercise plus liraglutide for one year.

Compared with placebo, the exercise group lost a further 4.1 kg, the liraglutide group 6.8 kg, and the combination group 9.5 kg. The combination also roughly doubled the reduction in body fat percentage seen with either treatment alone, and improved insulin sensitivity and cardiorespiratory fitness.

S-LiTE used structured sessions of about 150 minutes of moderate or 75 minutes of vigorous exercise a week, not a step count, and it used liraglutide at the full weight management dose. It does not test microdosing. What it does show is that exercise and a GLP-1 add together rather than overlap, which is the core reason to keep movement on the protocol.

How many steps a day are worth aiming for?

The data points to 7,000 to 10,000

A target of 7,000 to 10,000 steps a day covers most of the health benefit seen in the large step count studies. The Steps for Health Collaborative, led by Amanda Paluch and published in Lancet Public Health in 2022, pooled 15 cohorts with 47,471 adults. Compared with the lowest quartile, averaging about 3,550 steps a day, the risk of death over follow up was 40 percent lower at about 5,800 steps, 45 percent lower at about 7,850, and 53 percent lower at about 10,900.

The same analysis found the curve flattened at around 6,000 to 8,000 steps a day for adults aged 60 and over and 8,000 to 10,000 for younger adults. Step pace mattered less than step volume once total steps were accounted for.

These are observational associations, and people who walk more also tend to differ in other ways. The numbers still give a sensible target. For someone starting at 3,000 to 4,000 steps, adding about 1,000 a day every week or two is easier to sustain than jumping straight to 10,000.

Does a walk after meals help on a GLP-1?

Two to ten minutes is enough to register

A short, easy walk after eating lowers the rise in blood sugar that follows the meal. Buffey and colleagues pooled seven studies in Sports Medicine in 2022 and found that light walking after meals reduced the post meal glucose response compared with sitting, with effects seen from as little as 2 to 5 minutes. Standing helped a little. Walking helped more.

Working muscles take up glucose without needing as much insulin, so a walk in the first 30 to 60 minutes after eating catches the glucose peak as it forms. GLP-1 medicines already flatten post meal glucose by slowing stomach emptying and boosting insulin release when glucose is high, and a walk works through a separate route. The CGM article on this site shows how the two effects look on a glucose trace.

Many people on a GLP-1 also say a gentle walk eases post meal fullness and bloating. That fits with what is known about movement and gut transit, but it has not been tested in GLP-1 users. Hard exercise straight after a large meal can do the opposite and bring on nausea, so the walk should stay easy.

How can you keep NEAT up on a GLP-1 microdose?

Five habits that hold the line

Keeping NEAT steady mostly comes down to measuring it and making movement the default rather than a decision. These are general ideas to discuss with a healthcare provider, not an individual plan.

What is still unknown about NEAT and GLP-1 medicines?

Gaps worth naming

Nobody has yet measured how daily step counts change on semaglutide or tirzepatide with continuous accelerometry in a large trial. Some rodent studies report lower spontaneous activity with GLP-1 agonists, but rodent activity does not translate cleanly to people, and the human effect may be no larger than that of any calorie deficit.

Microdosing adds another layer of uncertainty. A smaller dose may cause less nausea and fatigue, and so less loss of movement, but that is a reasonable expectation rather than a tested result. Tracking steps on a phone or watch turns that open question into something each person can see for themselves.

Frequently Asked Questions